Simplex Trading
BCYC

Simplex Trading’s Bicycle Therapeutics BCYC Stock Holding History

Simplex Trading’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$854K Buy
184,000
+173,000
+1,573% +$989K ﹤0.01% 2676
2025
Q4 		$77.9K Buy
11,000
+10,100
+1,122% +$74.5K ﹤0.01% 5250
2025
Q3 		$6K Sell
900
-100
-10% -$755 ﹤0.01% 8160
2025
Q2 		$6K Sell
1,000
-2,100
-68% -$16.7K ﹤0.01% 7618
2025
Q1 		$26K Buy
3,100
+2,500
+417% +$29.5K ﹤0.01% 6353
2024
Q4 		$8K Buy
600
+400
+200% +$8.57K ﹤0.01% 7306
2024
Q3 		$4K Hold
200
– – ﹤0.01% 7687
2024
Q2 		$4K Buy
200
+100
+100% +$2.26K ﹤0.01% 7947
2024
Q1 		$2K Sell
100
-63,600
-100% -$1.35M ﹤0.01% 8362
2023
Q4 		$1.15M Sell
63,700
-3,700
-5% -$61.2K ﹤0.01% 2881
2023
Q3 		$1.35M Buy
67,400
+6,800
+11% +$155K ﹤0.01% 2397
2023
Q2 		$1.55M Buy
60,600
+47,400
+359% +$1.1M ﹤0.01% 2192
2023
Q1 		$280K Sell
13,200
-700
-5% -$17.6K ﹤0.01% 3919
2022
Q4 		$411K Buy
13,900
+13,100
+1,638% +$351K ﹤0.01% 3380
2022
Q3 		$18K Buy
800
+100
+14% +$2.38K ﹤0.01% 7611
2022
Q2 		$11K Buy
+700
New +$14.8K ﹤0.01% 8182
2022
Q1 		– Sell
-1,400
Closed -$85K – 10378
2021
Q4 		$85K Buy
+1,400
New +$77.2K ﹤0.01% 6496

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's BCYC Position: Q1 2026 in Review

Simplex Trading sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 19,986 shares — an estimated $114K sold.

Simplex Trading first reported a position in BCYC in Q4 2021 and held it in 12 quarters. The position peaked at $1.7M in Q2 2023. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Simplex Trading reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 19,986 Bicycle Therapeutics shares in Q1 2026, an estimated $114K.
  • Simplex Trading first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 12 quarters.
  • Simplex Trading's Bicycle Therapeutics position peaked at $1.7M in Q2 2023.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.